-
A Quantitative Exploration of Challenges to the Sustainability of the United States Biosimilar Market
Mar 10, 2025, 14:00 PM -
Treatment Patterns and Healthcare Resource Use (HRU) in Patients With Metastatic Melanoma (mMEL) Treated With BRAF-MEK Inhibitor Targeted Therapies (TTs)
Mar 10, 2025, 14:00 PM -
Review of Cell Therapy Access Landscape
Mar 10, 2025, 14:00 PM -
Reviewing Current Trends Regarding Use of Artificial Intelligence in Generating Real-World Evidence From Patient Medical Charts
Mar 10, 2025, 14:00 PM -
Cost-effectiveness Analysis of Ferric Carboxymaltose (Renegy®) for the Treatment of Iron Deficiency Anemia During Pregnancy: The Mexican Social Security Institute (IMSS) Perspective
Mar 10, 2025, 14:00 PM -
Cost-Utility of Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Disease Prevention Among Colombian Infants
Mar 10, 2025, 14:00 PM -
Travel Burden of Beta-Thalassemia Patients Receiving Red Blood Cell Transfusions in the Brazilian Public Healthcare System: A Real-World Study
Mar 10, 2025, 14:00 PM -
Inpatient Hospitalization Trends for COPD in 2018 versus 2021 in United States: A Retrospective Analysis
Mar 10, 2025, 14:00 PM -
The HER2-TRENDS StudyHR Positive - HER2 Negative Metastatic Breast Cancer (mBC) Treatment Patterns and Clinical Outcomes in Canada
Mar 10, 2025, 14:00 PM -
Adjusted Comparison of Amivantamab in Combination With Carboplatin Plus Pemetrexed From the PAPILLON Study Versus US Real-World Frontline Treatments in Patients With Advanced NSCLC Harboring EFGR Exon 20 Insertions
Mar 10, 2025, 14:00 PM -
Patient Reported Outcomes in BRUIN CLL-321: A Phase 3 Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Mar 10, 2025, 14:00 PM -
Evaluating the Application of GPT-4o and Retrieval-Augmented Generation (RAG) for Assessing Risk of Bias and Study Quality in Systematic Literature Reviews (SLRs): Preliminary Findings from a Comparative Study
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns, Healthcare Costs and Resource Utilization in First-Line Treatment of Metastatic NSCLC in the US using MarketScan® data
Mar 10, 2025, 14:00 PM -
Healthcare Costs Associated With Adverse Events During Treatment Episodes for Pediatric Attention-Deficit/Hyperactivity Disorder
Mar 10, 2025, 14:00 PM -
Clinical and Economic Burden of Non-Obstructive Hypertrophic Cardiomyopathy: A Literature Review
Mar 10, 2025, 14:00 PM -
Performance of Unanchored Population-Adjusted Indirect Comparison Methods in Rare Disease Settings: A Simulation Study
Mar 10, 2025, 14:00 PM -
Investing in Optimized HIV Prevention Among Young Men Who Have Sex With Men in Brazil: Insights From Fiscal Health Modeling
Mar 10, 2025, 14:00 PM -
A Health Economic Evaluation of an Artificial Intelligence-Assisted Prescription Review System in a Real-World Setting in China
Mar 10, 2025, 14:00 PM -
Impact of Circulating Tumor DNA (ctDNA) Burden Among Patients with Head and Neck Dquamous Cell Carcinoma (HNSCC) - A RWE Analysis
Mar 10, 2025, 14:00 PM -
State of Inclusion of Patient-Centered Endpoints in Duchenne Muscular Dystrophy (DMD) Clinical Trials
Mar 10, 2025, 14:00 PM
